# Episode Description for feed.xml

Evidence-based guide to cardiovascular supplements and medications for 40-year-old men, covering what works, what fails spectacularly, and optimal dosing protocols. Learn why high-dose omega-3 reduces heart attacks by 25% but increases atrial fibrillation risk by 50%, how CoQ10 cut heart failure mortality by 49% in the Q-SYMBIO trial, and why vitamin D and niacin failed despite decades of hype. Full research report: https://yudame.github.io/research/podcast/episodes/2025-11-21-cardiovascular-health-episode-4-supplementation/report.md

**Key Sources:**
• REDUCE-IT Trial (omega-3 EPA): https://www.ahajournals.org/doi/10.1161/JAHA.119.013543
• Q-SYMBIO Trial (CoQ10 & heart failure): https://www.ahajournals.org/doi/10.1161/circheartfailure.115.002639
• VITAL Trial (vitamin D & omega-3): https://prevmed.bwh.harvard.edu/vital/
• USPSTF Aspirin Guidelines (2022): https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
• JUPITER Trial (statin primary prevention): https://www.nejm.org/doi/full/10.1056/NEJMoa0807646

**Keywords:** omega-3, EPA, DHA, statins, aspirin, CoQ10, magnesium, vitamin D, plant sterols, aged garlic extract, red yeast rice, supplement timing, drug interactions, cardiovascular health, heart disease prevention

**Episode:** 4 of ongoing cardiovascular optimization series
**Duration:** 37:39
**Previous episodes:** Lifestyle factors (Ep 1), VO2 max (Ep 2), HRV (Ep 3)
